Skip to content
Torpedo Therapeutics logo

Torpedo Therapeutics

Torpedo Therapeutics is a YC Winter 2022 (W22) company. Based in Boston, MA, USA. Team of 5.

  • Neurotechnology
  • Medical Devices
  • Biotech

About Torpedo Therapeutics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Torpedo Therapeutics builds implantable deep brain stimulation devices that both sense and stimulate neural activity with higher spatial precision than current commercial electrodes. The devices target patients with Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy, replacing today's open-loop DBS systems that stimulate continuously, lack real-time neural feedback, and require repeated clinic visits to reprogram. The closed-loop design adjusts stimulation based on live neural signals, reducing off-target activation and battery drain from the implanted pulse generator.

From the Y Combinator listing

How Torpedo Therapeutics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

High-precision, closed-loop neuromodulation devices

We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.

Facts

Industry
Healthcare / Healthcare -> Medical Devices
Location
Boston, MA, USA
Team size
5
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works